rosiglitazone has been researched along with Proteinuria in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, M; Huang, Y; Lei, Y; Liu, R; Wang, X; Yu, X; Zheng, Z | 1 |
| Cattran, D; Dike, M; Eddy, A; Fogo, AB; Gipson, DS; Joy, MS; Kopp, JB; Powell, L; Thompson, A; Trachtman, H; Vento, S | 1 |
| Georgianos, PI; Lasaridis, AN; Sarafidis, PA; Saratzis, AN; Stafylas, PC | 1 |
| Arora, MK; Balakumar, P; Reddy, K | 1 |
| Chan, LY; Guo, H; Lai, KN; Leung, JC; Tang, SC | 1 |
| Bornstein, SR; Gross, P; Herbrig, K; Passauer, J; Pistrosch, F; Schwanebeck, U | 1 |
| Acikel, C; Bingol, N; Caglar, K; Eyileten, T; Gok, DE; Kilic, S; Oguz, Y; Sonmez, A; Vural, A; Yenicesu, M; Yilmaz, MI | 1 |
| Ecelbarger, CA; Hu, X; Khan, O; Riazi, S; Song, J; Wade, JB | 1 |
| Adler, S; Banz, W; Cho, KW; Davis, J; Higginbotham, A; Kim, YC; Moustaid-Moussa, N; O'Connor, T; Peterson, R; Shay, N; Tebbe, A | 1 |
| den Ouden, K; Goldschmeding, R; Joles, JA; Nguyen, TQ; Verhaar, MC; Westerweel, PE | 1 |
| Best, JD; Fairley, KF; Farish, S; Kincaid-Smith, P; Proietto, J | 1 |
| Al-Barazanji, KA; Bond, B; Buckingham, RE; Clapham, JC; Connor, SC; Slaughter, M; Toseland, CD; Turner, NC; West, A | 1 |
| Buckingham, RE; Lister, CA; Smith, SA; Toseland, CD | 1 |
1 review(s) available for rosiglitazone and Proteinuria
| Article | Year |
|---|---|
Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis.
Topics: Albuminuria; Diabetic Nephropathies; Disease Progression; Humans; Hypoglycemic Agents; Pioglitazone; PPAR gamma; Proteinuria; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones | 2010 |
4 trial(s) available for rosiglitazone and Proteinuria
| Article | Year |
|---|---|
Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group.
Topics: Administration, Oral; Adolescent; Age Factors; Body Surface Area; Canada; Child; Child, Preschool; Drug Resistance; Female; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney; Male; Proteinuria; Rosiglitazone; Serum Albumin; Steroids; Thiazolidinediones; Time Factors; Treatment Outcome; United States; Young Adult | 2009 |
Effect of thiazolidinedione treatment on proteinuria and renal hemodynamic in type 2 diabetic patients with overt nephropathy.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Hemodynamics; Humans; Hypoglycemic Agents; Kidney; Male; Middle Aged; Pilot Projects; PPAR gamma; Proteinuria; Renal Circulation; Rosiglitazone; Severity of Illness Index; Thiazolidinediones | 2012 |
Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria.
Topics: Adipocytes; Adiponectin; Adult; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Intercellular Signaling Peptides and Proteins; Male; Matched-Pair Analysis; Middle Aged; Models, Biological; PPAR gamma; Proteinuria; Reference Values; Rosiglitazone; Thiazolidinediones | 2004 |
Reduction of proteinuria by rosiglitazone in non-diabetic renal disease.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Body Mass Index; Cross-Over Studies; Diabetes Mellitus; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Obesity; PPAR gamma; Proteinuria; Retrospective Studies; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2008 |
8 other study(ies) available for rosiglitazone and Proteinuria
| Article | Year |
|---|---|
Rosiglitazone alleviates injury in rats with adenine‑induced chronic kidney disease.
Topics: Adenine; Animals; Creatinine; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Kidney Function Tests; Kidney Tubules; Male; Parathyroid Hormone; Phosphates; Proteinuria; Rats; Renal Insufficiency, Chronic; Rosiglitazone; Staining and Labeling; Thiazolidinediones | 2013 |
The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy.
Topics: Animals; Blood Glucose; Blood Urea Nitrogen; Creatinine; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Drug Interactions; Fenofibrate; Kidney; Lipids; Oxidative Stress; PPAR alpha; PPAR gamma; Proteinuria; Rats; Rosiglitazone; Thiazolidinediones | 2010 |
Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Drug Therapy, Combination; gamma-Globulins; Glomerulonephritis, IGA; Intercellular Adhesion Molecule-1; Kidney; Leukocytes, Mononuclear; Losartan; Mesangial Cells; Nephrectomy; PPAR gamma; Proteinuria; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta | 2011 |
Regulation of the renal thiazide-sensitive Na-Cl cotransporter, blood pressure, and natriuresis in obese Zucker rats treated with rosiglitazone.
Topics: Aging; Animals; Blood Glucose; Blood Pressure; Body Weight; Glucose Tolerance Test; Hypoglycemic Agents; Immunoblotting; Immunoenzyme Techniques; Kidney; Male; Natriuresis; Obesity; PPAR gamma; Proteinuria; Rats; Rats, Zucker; Receptors, Drug; Rosiglitazone; Sodium Chloride; Sodium Chloride Symporters; Solute Carrier Family 12, Member 3; Symporters; Telemetry; Thiazolidinediones; Tissue Distribution | 2005 |
Soy protein and isoflavones influence adiposity and development of metabolic syndrome in the obese male ZDF rat.
Topics: Adiposity; Animals; Blood Glucose; Caseins; Hypoglycemic Agents; Isoflavones; Kidney Diseases; Liver; Male; Metabolic Syndrome; Milk Proteins; Obesity; Proteinuria; Rats; Rats, Inbred Strains; Rosiglitazone; Soybean Proteins; Thiazolidinediones | 2007 |
Amelioration of anti-Thy1-glomerulonephritis by PPAR-gamma agonism without increase of endothelial progenitor cell homing.
Topics: Aneurysm; Animals; Blood Pressure; Bone Marrow Transplantation; Cell Movement; Disease Models, Animal; Endothelial Cells; Extracellular Matrix; Fibronectins; Gene Expression; Glomerulonephritis, Membranous; Hypoglycemic Agents; Isoantibodies; Kidney Cortex; Kidney Glomerulus; Male; Membrane Proteins; Plasminogen Activator Inhibitor 1; PPAR gamma; Proteinuria; Rats; Rats, Inbred BN; Rosiglitazone; Stem Cells; Thiazolidinediones; Transforming Growth Factor beta; Urea | 2008 |
Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats.
Topics: Acetylglucosaminidase; Albuminuria; Animals; Blood Pressure; Body Weight; Histocytochemistry; Hypoglycemic Agents; Immunohistochemistry; Islets of Langerhans; Kidney; Kidney Diseases; Male; Obesity; Pancreas; Pancreatic Diseases; Proteinuria; Rats; Rats, Zucker; Rosiglitazone; Systole; Thiazoles; Thiazolidinediones | 1998 |
Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat.
Topics: Aging; Animals; Cataract; Diabetes Mellitus, Type 2; Glucagon; Hyperglycemia; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Pancreas; Proteinuria; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones; Thinness; Thirst; Time Factors | 2000 |